We are live on ! Find out more
TOVX icon

Theriva Biologics
TOVX

34 hedge funds and large institutions have $3.32M invested in Theriva Biologics in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

26% more funds holding

Funds holding: 27 → 34 (+7)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

15% less capital invested

Capital invested by funds: $3.91M → $3.32M (-$591K)

Holders
34
Holders Change
+7
Holders Change %
+25.93%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$137K
2
Two Sigma Investments
Two Sigma Investments
New York
+$95.2K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$47K
4
UBS Group
UBS Group
Switzerland
+$26.1K
5
Citadel Advisors
Citadel Advisors
Florida
+$16.5K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$28.7K
2
Victory Capital Management
Victory Capital Management
Texas
-$498
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$925K – – –
BlackRock
2
BlackRock
New York
$863K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$448K +$9.96K +80 +2%
State Street
4
State Street
Massachusetts
$217K – – –
GCP
5
GSA Capital Partners
United Kingdom
$126K +$137K +1,101 New
Northern Trust
6
Northern Trust
Illinois
$113K – – –
Two Sigma Investments
7
Two Sigma Investments
New York
$98K +$95.2K +765 +879%
William Blair & Company
8
William Blair & Company
Illinois
$94K +$16.2K +130 +19%
VF
9
Virtu Financial
New York
$88K -$28.7K -231 -23%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$59K +$47K +378 +280%
Fisher Asset Management
11
Fisher Asset Management
Washington
$58K – – –
MP
12
MSD Partners
New York
$53K – – –
BCM
13
Bridgeway Capital Management
Texas
$34K – – –
UBS Group
14
UBS Group
Switzerland
$24K +$26.1K +210 New
Citadel Advisors
15
Citadel Advisors
Florida
$20K +$16.5K +133 +317%
Manulife (Manufacturers Life Insurance)
16
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$11K – – –
SCM
17
Sterneck Capital Management
Missouri
$11K – – –
Morgan Stanley
18
Morgan Stanley
New York
$10K +$10.3K +83 +8,300%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$10K +$10.9K +88 New
Victory Capital Management
20
Victory Capital Management
Texas
$9K -$498 -4 -5%
JCM
21
Jacobi Capital Management
Pennsylvania
$9K – – –
CWA
22
Clearview Wealth Advisors
Oregon
$9K +$995 +8 +11%
Mercer Global Advisors
23
Mercer Global Advisors
Colorado
$9K +$9.96K +80 New
TRCT
24
Tower Research Capital (TRC)
New York
$6K +$5.23K +42 +382%
HF
25
HRT Financial
New York
$6K +$6.84K +55 New
1
2

TOVX Hedge Fund Activity: Q3 2021 in Review

34 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Theriva Biologics (TOVX) for Q3 2021, worth a combined $3.32M — down 15% from $3.91M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TOVX positions and 0 closed out — a net gain of 7 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was GSA Capital Partners, opening a new position worth an estimated $137K. The largest seller was Virtu Financial, cutting an estimated $28.7K.

  • 34 institutional investors held Theriva Biologics (TOVX) as of Q3 2021, up from 27 in Q2 2021.
  • Funds reported $3.32M of Theriva Biologics stock for Q3 2021, down 15% quarter-over-quarter.
  • 7 funds opened new Theriva Biologics positions in Q3 2021 and 0 closed out, a net change of +7 holders.
  • The largest Theriva Biologics buyer in Q3 2021 was GSA Capital Partners, an estimated $137K added.
  • The largest Theriva Biologics seller in Q3 2021 was Virtu Financial, an estimated $28.7K sold.

Based on aggregated 13F filings for Q3 2021.